Skip to main content
Caplight Logo









JDRF

JDRF

New York City, New Yorkbreakthrought1d.org

Overview

JDRF, now known as Breakthrough T1D, is a global non-profit organization that funds type 1 diabetes (T1D) research and makes venture philanthropy investments through its JDRF T1D Fund to accelerate the development of commercial therapies.

Year Founded

1970

Portfolio Companies

45

Investments

JDRF investments
CompanyDateStageLead
ImmunocoreMar 2020Series BCo-investor
BiolinqNov 2021Series BCo-investor
Diasome PharmaceuticalsJul 2017Series A-
Ahead TherapeuticsJan 2026GrantLead
Integrated Medical SensorsJun 2023GrantCo-investor
Book a demo to see all 45 portfolio companies

For institutional investors. Book with your work email.

Key People

Jeremy Lott

International Board of Directors - Member, Finance Committee Member

Nanette DeTurk

Director, Emeritus

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is JDRF based?

JDRF is headquartered in New York City, New York, United States.

When was JDRF founded?

JDRF was founded in 1970.

How many portfolio companies does JDRF have?

JDRF has 45 portfolio companies in Caplight's dataset.

What are some companies in JDRF's portfolio?

Portfolio companies visible on Caplight include Immunocore, Biolinq, Diasome Pharmaceuticals, Ahead Therapeutics, Integrated Medical Sensors.

What was JDRF's most recent investment shown here?

JDRF's most recent investment in this portfolio sample was in Ahead Therapeutics in 2026.

What sectors does JDRF focus on?

JDRF focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech.

What company stages does JDRF focus on?

JDRF typically invests at the MultiStage stage.

What is JDRF's AUM?

JDRF's assets under management are estimated between $175.0M and $175.0M.

Firmographic Details

HeadquartersNew York City, New York
Year Founded1970

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?